Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study
阿帕替尼联合卡瑞利珠单抗治疗复发/转移性鼻咽癌的前瞻性多中心Ⅱ期临床研究
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2023.1298418
Yunyan Mo #, Yufei Pan #, Bin Zhang #, Jian Zhang #, Yixin Su #, Zhengchun Liu #, Meiqing Luo, Guanjie Qin, Xiangyun Kong, Rongjun Zhang, Yu Pan, Yi Liang, Defeng Wang, Yuejia Wei, Hengwei Chen, Wei Jiang